Arvinas Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases. | ||
Type | Type Public | Type Public |
Tags | ||
Locations | Locations New Haven, US HQ | Locations South San Francisco, US HQ Bothell, US Seattle, US |
Employees | Employees 13329% increase | Employees 188 |
Valuation ($) | Valuation ($) 1.9 b | Valuation ($) 243.3 m |
Financial | ||
Revenue (est.) | Revenue (est.) $78.5m (FY, 2023) | Revenue (est.) $130k (FY, 2023) |
Net income | Net income ($367.3m) (FY, 2023) | Net income ($234.6m) (FY, 2023) |
Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
View company